Pain reliever 'linked to lower prostate cancer risk'

Pain reliever 'linked to lower prostate cancer risk'

Pain reliever acetaminophen has been associated with a lower risk of prostate cancer, making some older men less dependent on assisted living.

Researchers found that taking 30 acetaminophen tablets or more a month for five plus years was linked to an estimated 38 per cent lower risk of prostate cancer, according to research published in journal Cancer Epidermiology, Biomarkers and Prevention.

Dr Eric Jacobs, American Cancer Society epidemiologist, warned that the findings needed to be replicated by other studies and do not justify the use of the drug to prevent prostate cancer.

"Still, results of this study could lead to further research on acetaminophen that might provide biological insights about the process of prostate cancer development and how this process could be slowed," he added.

Meanwhile, scientists at the University of California Los Angeles have developed a test which they believe could more accurately diagnose prostate cancer.

Find the nearest Barchester care home